Dandekar Atul (CIK 2050167) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy MAZE (7,500 shares), Sell MAZE (7,500 shares), Buy MAZE (7,500 shares), Sell MAZE (7,500 shares), Buy MAZE (7,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Maze Therapeutics, Inc. (MAZE) | CSBO | Buy | 7,500 | $78,150 |
| 2026-07-01 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 7,500 | $210,150 |
| 2026-06-02 | Maze Therapeutics, Inc. (MAZE) | CSBO | Buy | 7,500 | $78,150 |
| 2026-06-02 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 7,500 | $197,554 |
| 2026-05-01 | Maze Therapeutics, Inc. (MAZE) | CSBO | Buy | 7,500 | $78,150 |
| 2026-05-01 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 7,500 | $190,299 |
| 2026-03-03 | Maze Therapeutics, Inc. (MAZE) | CSBO | Buy | 7,500 | $78,150 |
| 2026-03-03 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 3,739 | $168,741 |
| 2026-03-03 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 3,761 | $171,953 |
| 2026-02-02 | Maze Therapeutics, Inc. (MAZE) | CSBO | Buy | 7,500 | $78,150 |
| 2026-02-02 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 1,200 | $51,816 |
| 2026-02-02 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 3,500 | $154,140 |
| 2026-02-02 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 2,800 | $126,028 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | CSBO | Buy | 72,400 | $754,408 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 66,365 | $2.7M |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 6,035 | $248,220 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | CSBO | Buy | 100 | $1,042 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | CSBO | Sell | 100 | $4,036 |
Source: SEC Form 4 filings · as of 2026-07-01